Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogen (NEOG) EBITDA: 2010-2025

Historic EBITDA for Neogen (NEOG) over the last 15 years, with Aug 2025 value amounting to -$16.1 million.

  • Neogen's EBITDA fell 812.94% to -$16.1 million in Q3 2025 from the same period last year, while for Aug 2025 it was -$1.1 billion, marking a year-over-year decrease of 2683.09%. This contributed to the annual value of -$1.1 billion for FY2025, which is 1908.63% down from last year.
  • Per Neogen's latest filing, its EBITDA stood at -$16.1 million for Q3 2025, which was up 97.37% from -$611.2 million recorded in Q2 2025.
  • Neogen's EBITDA's 5-year high stood at $23.4 million during Q2 2023, with a 5-year trough of -$611.2 million in Q2 2025.
  • Moreover, its 3-year median value for EBITDA was $12.0 million (2024), whereas its average is -$89.0 million.
  • Its EBITDA has fluctuated over the past 5 years, first surged by 288.94% in 2023, then tumbled by 4,787.00% in 2025.
  • Over the past 5 years, Neogen's EBITDA (Quarterly) stood at $12.5 million in 2021, then slumped by 161.40% to -$7.7 million in 2022, then soared by 288.94% to $14.5 million in 2023, then slumped by 3,262.70% to -$457.5 million in 2024, then tumbled by 812.94% to -$16.1 million in 2025.
  • Its EBITDA was -$16.1 million in Q3 2025, compared to -$611.2 million in Q2 2025 and $5.4 million in Q1 2025.